Skip to main content
. 2022 Feb 3;11(2):757–770. doi: 10.1007/s40121-022-00596-x

Fig. 2.

Fig. 2

Percentage of participants with ANC below the DAIDS threshold for Black/African American and the FDA threshold for other than Black/African American participants (a) and geometric mean (b) and geometric mean ratio (c) of ANC within 7 days after each dose and overall (neutropenia safety set). ANC absolute neutrophil count, RR risk ratio, DAIDS Division of Acquired Immunodeficiency Syndrome, FDA US Food and Drug Administration. aUpper limit is 26.5. Error bars represent 95% confidence intervals. The area of the orange circles is proportional to the values of risk ratios/between-group ratios